Alterola Biotech

(OTC) ABTI

Current Price$0.01

Market Cap$7.44M

Since IPO (2021)-100%

5 Year-100%

1 Year+42%

1 Month+0%

Alterola Biotech Financials at a Glance

Market Cap

$7.44M

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.20M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

32.78 (High)

Dividend

$0.00

Beta (Volatility)

32.78 (High)

Price

$0.01

Volume

Open

$0.01

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.20

Estimated Earnings Date

Nov 27, 2025

Dividend

$0.00

Beta (Volatility)

32.78 (High)

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.20

Estimated Earnings Date

Nov 27, 2025

ABTI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alterola Biotech

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

David John Hitchcock

Website

alterola-abti.com

Headquarters

Birkenhead, CH41 5AR, GB

ABTI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-19%

Return on Assets

-12%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.44M

Shares Outstanding

1.46B

Volume

Avg. Volume

0.016

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$1.90M

EBITDA

-$1.70M

Operating Cash Flow

-$1.04M

Capital Expenditure

-$139.80K

Free Cash Flow

-$1.18M

Cash & ST Invst.

$8.89K

Total Debt

$1.41M

Alterola Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.44M

N/A

Market Cap/Employee

$7.44M

N/A

Employees

N/A

Net Income

-$123.16K

+67.2%

EBITDA

-$123.16K

+73.8%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Total Cash

$9.10K

-39.8%

Total Debt

$1.55M

+204.4%

Accounts Receivable

-$9.10K

-125.4%

Inventory

$975.00

+9.2%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.55M

+317.2%

Return on Assets

-12.46%

N/A

Return on Invested Capital

-18.51%

N/A

Free Cash Flow

-$122.16K

+38.1%

Operating Cash Flow

-$122.16K

+38.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CMVLFCellectis S.A.

CMVLFCellectis S.A.$3.47+12.66%

EDTXFSpectral Medical Inc.

EDTXFSpectral Medical Inc.$0.96-2.54%

DMTRF3-D Matrix, Ltd.

DMTRF3-D Matrix, Ltd.$2.25+0.00%

CPHRFCipher Pharmaceuticals Inc.

CPHRFCipher Pharmaceuticals Inc.$11.41-1.30%

NIKANika Pharmaceuticals Inc.

NIKANika Pharmaceuticals Inc.$0.51+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.84+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.87-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$82.80+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.82-0.07%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$186.80-0.03%

INTCIntel

INTCIntel$133.77+0.10%

NVDANvidia

NVDANvidia$210.12+0.03%

Questions About ABTI

What is the current price of Alterola Biotech?

Alterola Biotech is trading at $0.01 per share.

What is the 52-week range for Alterola Biotech?

Over the past 52 weeks, Alterola Biotech has traded between $0.00 and $0.20.

How much debt does Alterola Biotech have?

As of the most recent reporting period, Alterola Biotech reported total debt of $2.35M.

How much cash does Alterola Biotech have on hand?

Alterola Biotech reported $82.72K in cash and cash equivalents in its most recent financial results.

What is Alterola Biotech’s dividend yield?

Alterola Biotech does not currently have a dividend yield.

Alterola Biotech

Alterola Biotech Financials at a Glance

ABTI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alterola Biotech

ABTI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alterola Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ABTI

What is the current price of Alterola Biotech?

What is the 52-week range for Alterola Biotech?

How much debt does Alterola Biotech have?

How much cash does Alterola Biotech have on hand?

What is Alterola Biotech’s dividend yield?

Premium Investing Services